Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This blend combines three distinct mechanisms of action: tesa's growth hormone-releasing hormone (GHRH) analog properties, CJC1295's extended half-life characteristics, and ipamorelin's selective growth hormone secretagogue receptor activation
You simply pay for the medication
[3] These studies also suggest that DSIP could attenuate the excitatory actions of NMDA receptors, further contributing to its sleep-promoting properties
Deeper Dive into the Most Recent Publications Injectable Peptide Therapy in Sports Medicine (2026) Key findings: most peptides lack human clinical evidence significant research still needed before routine use Systematic Review of BPC-157 (2025) Key findings: consistent animal study benefits insufficient human clinical data Mechanisms of BPC-157 (2026) Key findings: angiogenesis and tissue repair pathways promising biology, limited clinical validation
